ACTU vs ELPW Comparison

Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3B, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.

Elong Power Holding Ltd is engaged in research and development, manufacturing, sales, and service of high-power lithium-ion batteries for electric vehicles and construction machinery, as well as large-capacity, long-cycle lithium-ion batteries for energy storage systems. The company's lower-cost, high-power, and fast-charging batteries are designed specifically for commercial vehicles and specialty vehicles that require large-capacity energy storage systems. It operates in one operating segment and includes the manufacture, commercialization, and distribution of a variety of battery cells and battery packs for use in a wide array of applications.